Ambu A/S (OTCMKTS:AMBBY) vs. Envoy Medical (NASDAQ:COCH) Head-To-Head Review

Ambu A/S (OTCMKTS:AMBBY) and Envoy Medical (NASDAQ:COCH) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, valuation, institutional ownership, profitability and analyst recommendations.

Earnings and Valuation

This table compares Ambu A/S and Envoy Medical”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ambu A/S	$894.37 million	3.06	$90.19 million	$0.30	38.80
Envoy Medical	$240,000.00	210.34	-$23.76 million	($0.76)	-0.86

Ambu A/S has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Ambu A/S, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Ambu A/S and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Ambu A/S	8.18%	8.49%	6.75%
Envoy Medical	-11,304.83%	N/A	-144.13%

Insider and Institutional Ownership

8.6% of Envoy Medical shares are held by institutional investors. 7.2% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Volatility & Risk

Ambu A/S has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 1.97, indicating that its share price is 97% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for Ambu A/S and Envoy Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ambu A/S	0	1	0	0	2.00
Envoy Medical	1	1	2	0	2.25

Envoy Medical has a consensus price target of $2.17, suggesting a potential upside of 231.29%. Given Envoy Medical’s stronger consensus rating and higher probable upside, analysts plainly believe Envoy Medical is more favorable than Ambu A/S.

Summary

Envoy Medical beats Ambu A/S on 7 of the 13 factors compared between the two stocks.

About Ambu A/S

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. The company was founded in 1937 and is headquartered in Ballerup, Denmark.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.